1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with pterostilbene in 1 studies
| Studies (1,4,7-triazacyclononane-n,n',n''-triacetic acid) | Trials (1,4,7-triazacyclononane-n,n',n''-triacetic acid) | Recent Studies (post-2010) (1,4,7-triazacyclononane-n,n',n''-triacetic acid) | Studies (pterostilbene) | Trials (pterostilbene) | Recent Studies (post-2010) (pterostilbene) |
|---|---|---|---|---|---|
| 195 | 3 | 161 | 549 | 8 | 480 |
| Protein | Taxonomy | 1,4,7-triazacyclononane-n,n',n''-triacetic acid (IC50) | pterostilbene (IC50) |
|---|---|---|---|
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 10 | |
| Neuronal acetylcholine receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | 0.82 | |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | 4.5867 | |
| Breakpoint cluster region protein | Homo sapiens (human) | 10 | |
| Neuronal acetylcholine receptor subunit beta-2 | Rattus norvegicus (Norway rat) | 0.82 | |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | 5.1 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.7 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.82 | |
| Transient receptor potential cation channel subfamily A member 1 | Rattus norvegicus (Norway rat) | 7.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shi, J; Tong, R; Wang, T; Xiong, L; Xu, K; Zhao, L | 1 |
1 review(s) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and pterostilbene
| Article | Year |
|---|---|
Recent research and development of NDM-1 inhibitors.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Binding Sites; Catalytic Domain; Drug Resistance, Bacterial; Molecular Docking Simulation; Picolinic Acids; Sulfonamides | 2021 |